Albers DS[au] - Search Results

Year	Number of Results
1995	1
1996	1
1997	1
1998	3
1999	3
2000	2
2001	4
2002	5
2003	4
2004	3
2013	1
2015	1
2018	2
2019	1
2024	1

1

New insights into progressive supranuclear palsy.

Albers DS, Augood SJ. Albers DS, et al. Trends Neurosci. 2001 Jun;24(6):347-53. doi: 10.1016/s0166-2236(00)01794-x. Trends Neurosci. 2001. PMID: 11356507 Review.

2

Mitochondrial dysfunction in progressive supranuclear palsy.

Albers DS, Beal MF. Albers DS, et al. Neurochem Int. 2002 May;40(6):559-64. doi: 10.1016/s0197-0186(01)00126-7. Neurochem Int. 2002. PMID: 11850113 Review.

3

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease.

Albers DS, Beal MF. Albers DS, et al. J Neural Transm Suppl. 2000;59:133-54. doi: 10.1007/978-3-7091-6781-6_16. J Neural Transm Suppl. 2000. PMID: 10961426 Review.

4

Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism.

Sonsalla PK, Albers DS, Zeevalk GD. Sonsalla PK, et al. Among authors: albers ds. Amino Acids. 1998;14(1-3):69-74. doi: 10.1007/BF01345245. Amino Acids. 1998. PMID: 9871444 Review.

5

Dopamine transmission in DYT1 dystonia.

Augood SJ, Hollingsworth Z, Albers DS, Yang L, Leung J, Breakefield XO, Standaert DG. Augood SJ, et al. Among authors: albers ds. Adv Neurol. 2004;94:53-60. Adv Neurol. 2004. PMID: 14509654 No abstract available.

6

Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.

Žiniauskaite A, Ragauskas S, Hakkarainen JJ, Rich CC, Baumgartner R, Kalesnykas G, Albers DS, Kaja S. Žiniauskaite A, et al. Among authors: albers ds. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3088-3093. doi: 10.1167/iovs.18-24432. Invest Ophthalmol Vis Sci. 2018. PMID: 30025146

7

Minocycline enhances MPTP toxicity to dopaminergic neurons.

Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS. Yang L, et al. Among authors: albers ds. J Neurosci Res. 2003 Oct 15;74(2):278-85. doi: 10.1002/jnr.10709. J Neurosci Res. 2003. PMID: 14515357

8

Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION).

Guo Y, Mehrabian Z, Johnson MA, Albers DS, Rich CC, Baumgartner RA, Bernstein SL. Guo Y, et al. Among authors: albers ds. Transl Vis Sci Technol. 2019 Dec 20;8(6):47. doi: 10.1167/tvst.8.6.47. eCollection 2019 Nov. Transl Vis Sci Technol. 2019. PMID: 31879569 Free PMC article.

9

Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice.

Li G, Torrejon KY, Unser AM, Ahmed F, Navarro ID, Baumgartner RA, Albers DS, Stamer WD. Li G, et al. Among authors: albers ds. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):383-392. doi: 10.1167/iovs.17-23212. Invest Ophthalmol Vis Sci. 2018. PMID: 29346804 Free PMC article.

10

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy.

Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD Jr, Beal MF. Albers DS, et al. Exp Neurol. 2001 Mar;168(1):196-8. doi: 10.1006/exnr.2000.7607. Exp Neurol. 2001. PMID: 11170735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year